Cystic Fibrosis Earns a New Bacterial Foe

Measuring the health status of cystic fibrosis (CF) patients would now get easier as researchers have found that exacerbations in CF are linked to chronic infection with a bacterium called Stenotrophomonas maltophilia.

The finding that chronic infection with S. maltophilia is independently linked with an increased risk of exacerbations gives clinicians and researchers a new potential target in fighting their disease as well.

Cystic Fibrosis - Symptoms, Causes, Diagnosis, Treatment, Support Groups
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has still to find its cure

"Our study showed that chronic infection with S. maltophilia, which was previously not regarded as prognostically significant, may have a real impact on the progression of CF in patients," said Valerie Waters of the Hospital for Sick Children in Toronto.

To assess whether S. maltophilia represented a true infection, rather than merely a colonizing organism, and whether it had an impact on the progression of disease, Waters and colleagues performed a two-stage study.

In the first stage, they sought to determine if S. maltophilia generated an immune response in CF patients.

For Some Patients With Cystic Fibrosis, Home Care Equivalent to Hospital Care
Researchers from Johns Hopkins University say that patients with cystic fibrosis (CF) recover from exacerbations equally well if they are treated at home or in a hospital.

In the second stage, they retrospectively followed almost 700 CF patients for 12 years to determine whether chronic infection with S. maltophilia was independently associated with an increased risk of exacerbation or lowered lung function.

They found that antibody levels to S. maltophilia flagellin, were about two times higher in chronically infected patients compared to those who were never infected, indicating a specific immune response and a true infection, rather than mere colonization.

How Cystic Fibrosis Causes Lung Disease
An advance in scientists' understanding of how cystic fibrosis (CF) causes lung disease in people with the condition has been made in a new research.

The increased antibody levels were also associated with lower lung function, as measured by FEV1 (forced expiratory volume in one second.)

Furthermore, they found that patients with chronic S. maltophilia infections had a 63 percent greater risk of exacerbations than those who had never been infected, although there were no significant differences detected in the rate of lung function decline.

Infliximab may Help Treat Cystic Fibrosis and Crohn's Disease
Cystic fibrosis (CF) is the most common life-threatening autosomal recessive disease in Caucasian children; it has an incidence of 1 case in every 2500 children born alive.

"It is crucial that we look to determine whether chronic S. maltophilia infection directly results in the worsening of lung function.

"We plan to investigate the effects of chronic S. maltophilia during pulmonary exacerbations in future studies," said Waters.

The findings were published online in the American Journal of Respiratory and Critical Care Medicine.

Source-ANI